Black Rock Inc. Sarepta Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,324,404 shares of SRPT stock, worth $141 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,324,404
Previous 5,960,370
73.22%
Holding current value
$141 Million
Previous $772 Million
111.4%
% of portfolio
0.04%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding SRPT
# of Institutions
501Shares Held
89.2MCall Options Held
1.39MPut Options Held
1.13M-
Capital International Investors Los Angeles, CA9.06MShares$123 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$123 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$55.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$45.8 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$36.4 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.19B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...